Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-13

Clinical Trial Update: CAMEO: Canadian Methotrexate and Etanercept Outcome Study [Phase 4]

View source ↗

Summary

Phase 4 Canadian trial (CAMEO) evaluating methotrexate in combination with etanercept for rheumatoid arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-06-13